Matches in Nanopublications for { ?s ?p "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP927276.RAt0rdIqVfDnPhH_ZWaV6bZe7NznUaY0lBU9s_qPBU-Dw130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927276.RAt0rdIqVfDnPhH_ZWaV6bZe7NznUaY0lBU9s_qPBU-Dw130_provenance.
- NP927283.RAlXTDat_pbQurXq-hippyUdw85pxJsK0DDNzizAHYThA130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927283.RAlXTDat_pbQurXq-hippyUdw85pxJsK0DDNzizAHYThA130_provenance.
- NP927259.RAD9pXY-H5FJ2QrzSTZBanWydDUvDh1zcT8I82M2luB0c130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927259.RAD9pXY-H5FJ2QrzSTZBanWydDUvDh1zcT8I82M2luB0c130_provenance.
- NP734329.RAmLaOr2vTrUoRc77iH5NQxIA6q1nP2TCmRUf220PwDns130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734329.RAmLaOr2vTrUoRc77iH5NQxIA6q1nP2TCmRUf220PwDns130_provenance.
- NP734333.RAoKsq87z5LqsZyjzjjVjWg5FyKSAdgSHmXjPA4UljTC8130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734333.RAoKsq87z5LqsZyjzjjVjWg5FyKSAdgSHmXjPA4UljTC8130_provenance.
- NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734334.RAi2aIB0luXehhiCRPnkzlj4Ougq6d1JG2FEKPcdT-Gbo130_provenance.
- NP927168.RAN0KYwY3XyOVr56CZiWTVFLvXRxDGXokpeqHq9wFxsz4130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927168.RAN0KYwY3XyOVr56CZiWTVFLvXRxDGXokpeqHq9wFxsz4130_provenance.
- NP734328.RA7OEactSCCnwIbuPFjOCX-nPQzOwnBMlXsAYJ4CieIa8130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734328.RA7OEactSCCnwIbuPFjOCX-nPQzOwnBMlXsAYJ4CieIa8130_provenance.
- NP734332.RAy_MaWTWeWocJx6qbg8o86Nym-jVQxoUIsbSCdwY4xrs130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734332.RAy_MaWTWeWocJx6qbg8o86Nym-jVQxoUIsbSCdwY4xrs130_provenance.
- NP927327.RA1HPal6B4g5f1iCXgyTFpqXdZ-tbYb0vo7msGcQ7QKTw130_assertion description "[In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927327.RA1HPal6B4g5f1iCXgyTFpqXdZ-tbYb0vo7msGcQ7QKTw130_provenance.